Financial Highlights

Financial Highlights

Five-Year Summary

The Five-year summary is presented in pound sterling, rounded to the nearest million. Financial information of 2015 was reported in South African rand and has been translated to sterling using the procedures outlined below:

  • Assets and liabilities were translated at the closing pound rates;
  • Income and expenses were translated at average pound exchange rates; and
  • Differences resulting from re-translation have been recognised in the foreign currency translation reserve
INCOME STATEMENTS

2019 

£'m

2018

£'m

2017

£'m

2016

£'m

2015

£'m

Revenue1 2 932 2 876 2 749 2 107 1 977
Operating (loss)/profit 81 (288) 362 288 345
(Loss)/profit after tax (130) (474) 243 190 254
Adjusted operating profit 330 370 360 335 318
Adjusted EBITDA 493 515 501 428 403
Adjusted earnings 198 221 220 219 193

 

EARNINGS PER SHARE

2019

pence

2018

pence

2017

pence

2016

pence

2015

pence

Basic (loss)/earnings basis (20.5) (66.7) 31.0 29.6 44.6
Diluted (loss)/earnings basis (20.5) (66.7) 31.0 29.5 43.8
Basic adjusted earnings basis 26.9 30.0 29.8 36.7 35.8
Diluted adjusted earnings basis 26.9 30.0 29.8 36.7 35.1
Dividends declared per share 7.90 7.90 7.90 7.90 9.33

 

STATEMENTS OF FINANCIAL POSITION

2019

£'m

2018

£'m

2017

£'m

2016

£'m

2015

£'m

ASSETS          
Non-current assets 5 337 5 382 6 353 5 604 3 654
Current assets 1 091 961 1 069 945 742
Total assets 6 428 6 343 7 422 6 549 4 396
           
EQUITY          
Owners of the parent 3 151 3 286 4 086 3 509 1 779
Non-controlling interest 115 87 78 61 61
Total equity 3 266 3 373 4 164 3 570 1 840
           
LIABILITIES          
Non-current liabilities 2 576 2 445 2 668 2 192 2 114
Current liabilities 586 525 590 787 442
Total liabilities 3 162 2 970 3 258 2 979 2 556
Total equity and liabilities 6 428 6 343 7 422 6 549 4 396

 

STATEMENTS OF CASH FLOWS 2019

2018

2017

2016

2015

Operating cash flow (£'m) 451 466 492 411 440
Adjusted EBITDA cash conversion (%) 91% 90% 98% 96% 109%

1 An income statement reclassification has increased Mediclinic Southern Africa 2018 revenue and cost of sales by £6m. Refer to note 2.1 of the 2019 Group annual financial statements.